Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.
World J Clin Cases. Apr 16, 2026; 14(11): 119670
Published online Apr 16, 2026. doi: 10.12998/wjcc.v14.i11.119670
Published online Apr 16, 2026. doi: 10.12998/wjcc.v14.i11.119670
Clinical profile and outcome of secondary glaucoma managed during the COVID-19 pandemic in a tertiary care institute
Bhagabat Nayak, Bhumija Bhatt, Sucheta Parija, Koyel Chakraborty, Jayadev Nanda, Bijnya Birajita Panda, Department of Ophthalmology, All India Institute of Medical Sciences, Bhubaneswar 751019, Odisha, India
Durgesh Prasad Sahoo, Department of Community Medicine and Family Medicine, All India Institute of Medical Sciences Bibinagar, Bibinagar 508126, Telangāna, India
Author contributions: Nayak B designed and conducted the study; Chakraborty K, Bhatt B, and Nanda J wrote the manuscript; Sahoo DP contributed to the statistical analyses; Nayak B, Parija S, and Panda BB provided clinical inputs and critically analyzed the manuscript; Nayak B supervised the study; Bhatt B acquired the clinical data, prepared the first draft of the manuscript, searched the literature, and was responsible for the preparation of figures; Nayak B and Panda BB critically analyzed the initial manuscript and provided crucial inputs that were essential for preparing the final version of the manuscript; Nayak B, Chakraborty K, Nanda J, and Panda BB helped in representing the figures correctly, formulating the discussion after proper literature review, and keeping up with the manuscript guidelines, which were essential for the final version of the manuscript.
Institutional review board statement: This study was reviewed and approved by the Ethics Committee of All India Institute of Medical Sciences, Bhubaneswar, Odisha, India, No. IEC-AIIMS BBSR/PG Thesis/2020-21/16.
Informed consent statement: Informed written consent was obtained from the patient for publication of this report and any accompanying images.
Conflict-of-interest statement: All authors declare that they have no conflict of interest to disclose.
STROBE statement: The authors have read the STROBE Statement-checklist of items, and the manuscript was prepared and revised according to the STROBE Statement-checklist of items.
Data sharing statement: All the responses from the participants of the study have been recorded in Excel table format and can be provided upon request to the corresponding author at bigyan_panda@yahoo.co.in/bhagabat80@gmail.com.
Corresponding author: Bijnya Birajita Panda, Assistant Professor, Department of Ophthal
Received: February 3, 2026
Revised: February 25, 2026
Accepted: March 16, 2026
Published online: April 16, 2026
Processing time: 65 Days and 17.8 Hours
Revised: February 25, 2026
Accepted: March 16, 2026
Published online: April 16, 2026
Processing time: 65 Days and 17.8 Hours
Core Tip
Core Tip: This study aimed to assess the clinical course of secondary glaucoma during the coronavirus disease 2019 (COVID-19) pandemic in a tertiary care institute in eastern India and compare them with that of a similar cohort in the post-pandemic period. The majority patients were male, of elderly age group and had pseudoexfoliation as the most common etiology. Target intraocular pressure was achieved in 65.9% of eyes after six months of treatment. There was an increase in mean retinal nerve fiber layer thickness post treatment which was statistically significant. After the pandemic, there was an increase in neovascular (27%) and other forms of secondary glaucoma, except lens-induced glaucoma.